Treatment strategies for focal epilepsy

Bibliography

• Bauer J, Buchmüller L, Reuber M, Burr W. Which patients become seizure free with antiepileptic drugs? An observational study in 821 patients with epilepsy. Acta Neurol Scand 2008;117:55-9
   PubMed Web of Science ®Google Scholar
• Sillanpää M, Schmidt D. Seizure clustering during drug treatment affects seizure outcome and mortality of childhood-onset epilepsy. Brain 2008;131:938-44
   PubMed Web of Science ®Google Scholar
• Wiebe S, Blume WT, Girvin JP, Eliasziw M. Effectiveness and efficiency of surgery for Temporal Lobe Epilepsy Study Group. A randomized, controlled trial of surgery for temporal-lobe epilepsy. N Engl J Med 2001;345:311-8
   PubMed Web of Science ®Google Scholar
• Marson AG, Al-Kharusi AM, Alwaidh M, et al. On behalf of the SANAD Study Group. Carbamazepine, gabapentin, lamotrigine, oxcarbazepine or topiramate for partial epilepsy: results from the SANAD trial. Lancet 2007;369:1000-15
   PubMed Web of Science ®Google Scholar
• Brodie MJ, Kwan P. Staged approach to epilepsy management. Neurology 2002;58(Suppl 5):S2-S8
   Web of Science ®Google Scholar
• Seconds European Working Group on Epilepsy. Epilepsy and driving. 3 April 2005 (handout of final report)
   Google Scholar
• Dulac O, Leppik IE, Chadwick DW, Specchio LM. Starting and stopping treatment. Second edition. In: Engel J Jr, Pedley TA editors, Epilepsy: a comprehensive textbook. Philadelphia: Wolter Kluwer/Lippincott Williams & Williams 2008;3101-1309
   Google Scholar
• Marson A, Jacoby A, Johnson A, et al. Immediate versus deferred antiepileptic drug treatment for early epilepsy and single seizures: a randomised controlled trial. Lancet 2005;365:2007-13
   PubMed Web of Science ®Google Scholar
• Gilad R, Lampl Y, Gabbay U, et al. Early treatment of single generalized tonic–clonic seizure to prevent recurrence. Arch Neurol 1996;53:1149-52
   PubMedGoogle Scholar
• First Seizure Trial Group. Randomized clinical trial on the efficacy of antiepileptic drugs in reducing the risk of relapse after a first unprovoked tonic-clonic seizure. Neurology 1993;43:478-83
   PubMed Web of Science ®Google Scholar
• Mattson RH, Cramer JA, Collins JF. Comparison of carbamazepine, phenobarbital, phenytoin and primidone in partial and secondarily generalized tonic–clonic seizures. N Engl J Med 1985;313:145-51
   PubMed Web of Science ®Google Scholar
• Beghi E, Berg AT, Shinnar S, Hauser WA. Treatment of single and infrequent seizures. Second edition. In: Engel J Jr, Pedley TA, editors, Epilepsy: a comprehensive textbook. Wolters Kluwer/Lippincott Williams & Wilkins; 2008:1327-1333
   Google Scholar
• Musicco M, Beghi E, Solari A, Viani F. Treatment of first tonic–clonic seizure does not improve the prognosis of epilepsy. Neurology 1997;49:991-8
   PubMed Web of Science ®Google Scholar
• Camfield P, Camfield C, Smith S, et al. Long-term outcome is unchanged by antiepileptic drug treatment after a first seizure: a 15-year follow-up from a randomized trial in childhood. Epilepsia 2002;43:662-3
   PubMedGoogle Scholar
• Harden CL. Antiepileptic drug teratogenensis. What are the risks for congenital malformations and adverse cognitive outcomes? Int Rev Neurobiol 2008;83:206-13
   Google Scholar
• Rowan AJ, Ramsay RE, Collins JF and the VA Cooperative Study 428 Group. New onset geriatric epilepsy: a randomized study of gabapentin, lamotrigine, and carbamazepine. Neurology 2005;64:1868-1873.
   PubMed Web of Science ®Google Scholar
• Brodie MJ, Overstall PW, Giorgi L. Multicentre, double-blind, randomised comparison between lamotrigine and carbamazepine in elderly patients with newly diagnosed epilepsy. Epilepsy Res 1999;37:81-7
   PubMed Web of Science ®Google Scholar
• Pugh MJ, van Cott AC, Cramer JA, et al. Trends in antiepileptic drugs prescribing for older patients with new-onset epilepsy: 2000–2004. Neurology 2008;70:2171-8
   PubMed Web of Science ®Google Scholar
• Stephen LJ, Brodie MJ. Seizure freedom with more than one antiepileptic drug. Seizure 2002;11:349-51
   PubMed Web of Science ®Google Scholar
• Luciano AL, Shorvon SD. Results of treatment changes in patients with apparently drug-resistant chronic epilepsy. Ann Neurol 2007;62:375-81
   PubMed Web of Science ®Google Scholar
• Gazzola DM, Balcer LJ, French JA. Seizure-free outcome in randomized add-on trials of the new antiepileptic drugs. Epilepsia 2007;48:1303-7
   PubMed Web of Science ®Google Scholar
• Bauer J, Ben-Menachem E, Krämer G, et al. Levetiracetam: a long-term follow-up study of efficacy and safety. Acta Neurol Scand 2006;114:169-76
   PubMedGoogle Scholar
• Wellmer S, Wellmer J, Bauer J. Zonisamide as add-on treatment of focal epilepsies. An outcome analysis in 74 patients (in German). Nervenarzt 2008. [Epub ahead of print]
   PubMedGoogle Scholar
• Faught E, Ayala R, Montouris GG, Leppik IE. Zonisamide 922 Trial Group. Randomized controlled trial of zonisamide for the treatment of refractory partial-onset seizures. Neurology 2001;57:1774-9
   PubMed Web of Science ®Google Scholar
• Brodie MJ, Duncan R, Vespignani H, et al. Dose-dependent safety and efficacy of zonisamide: a randomized, double-blind, placebo-controlled study in patients with refractory partial seizures. Epilepsia 2005;46:31-41
   Web of Science ®Google Scholar
• Schmidt D, Jacob R, Loiseau P, et al. Zonisamide for add-on treatment of refractory partial epilepsy: a European double-blind trial. Epilepsy Res 1993;15:67-73
   PubMed Web of Science ®Google Scholar
• Sackellares JC, Ramsay RE, Wilder BJ, et al. Randomized, controlled clinical trial of zonisamide as adjunctive treatment for refractory partial seizures. Epilepsia 2004;45:610-7
   PubMed Web of Science ®Google Scholar
• Beerlage S, Bauer J. Epilepsy treatment with topiramate. A 12- and 24-months treatment analysis in 98 patients (in German). Akt Neurol 2007;34:555-8
   Web of Science ®Google Scholar
• Chahem J, Bauer J. Treatment of epilepsy with third-line antiepileptic drugs: felbamate, tiagabine and sulthiame (in German). Nervenarzt 2007;78:1407-12
   PubMedGoogle Scholar
• Krakow K, Lengler U, Rettig K, et al. Topiramate in add-on therapy: results from an open-label, observational study. Seizure 2007;16:593-600
   PubMedGoogle Scholar
• Chung S, Wang N, Hank N. Comparative retention rates and long-term tolerability of new antiepileptic drugs. Seizure 2007;16:296-304
   PubMed Web of Science ®Google Scholar
• Bauer J, Ruocco A. Epilepsy therapy with pregabalin. Treatment follow-up in 103 patients (in German). Aktuel Neurol 2006;33:439-41
   Web of Science ®Google Scholar
• Peltola J, Peltola M, Auvinen A, et al. Retention rates of new antiepileptic drugs in localization-related epilepsy: a single-center study. Acta Neurol Scand 2009;119:55-60
   PubMedGoogle Scholar
• Loszadi D, Hemming K, Marson AG. Pregabalin add-on for drug-resistant partial epilepsy. Cochrane Database Syst Rev 2008;23(1):CD005612
   Google Scholar
• Michael B, Marson AG. Clobazam as an add-on in the management of refractory epilepsy. Cochrane Database Syst Rev 2008;16(2): CD004154
   Google Scholar
• De Herdt V, Boon P, Ceulemans B, et al. Vagus nerve stimulation for refractory epilepsy: a Belgian multicenter study. Eur J Paediatr Neurol 2007;11:261-9
   PubMedGoogle Scholar
• Morrow J, Russell A, Guthrie E, et al. Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register. J Neurol Neurosurg Psychiatry 2006;77:193-8
   PubMed Web of Science ®Google Scholar
• Cunnington M, Ferber S, Quartey G, et al. Effect of dose on the frequency of major birth defects following fetal exposure to lamotrigine monotherapy in an International Observational Study. Epilepsia 2007;48:1207-10
   PubMed Web of Science ®Google Scholar
• Montouris G. Safety of the newer antiepileptic drug oxcarbazepine during pregnancy. Curr Med Res Opin 2005;21:693-701
   PubMed Web of Science ®Google Scholar
• Holmes LB, Wyszynski DF, Liebermann E. The AED (antiepileptic drug) pregnancy registry: a 6-year experience. Arch Neurol 2004;61:673-8
   PubMed Web of Science ®Google Scholar
• Schramm J, Ral T, Grunwald T, Blümcke I. Surgical treatment for neocortical temporal lobe epilepsy: clinical and surgical aspects and seizure outcome. J Neurosurg 2001;94:33-42
   PubMed Web of Science ®Google Scholar
• Zentner J, Hufnagel A, Wolf HK, et al. Surgical treatment of temporal lobe epilepsy: clinical, radiological, and histopathological findings in 178 patients. J Neurol Neurosurg Psychiatry 1995;58:666-73
   PubMedGoogle Scholar
• Zentner J, Hufnagel A, Wolf HK, et al. Surgical treatment of neoplasms associated with medically intractable epilepsy. Neurosurgery 1997;41:378-86
   PubMed Web of Science ®Google Scholar
• Zentner J, Hufnagel A, Ostertun B, et al. Surgical treatment of extratemporal epilepsy: clinical, radiological, and histopathological findings in 60 patients. Epilepsia 1996;37:1072-80
   PubMedGoogle Scholar
• Li LM, Cendes F, Andermann F, et al. Surgical outcome in patients with epilepsy and dual pathology. Brain 1999;122:799-805
   PubMed Web of Science ®Google Scholar
• Bauer J, Reuber M. Medical treatment of epilepsy. Expert Opin Emerg Drugs 2003;8:457-67
   PubMedGoogle Scholar
• Bauer J. Treatment of epilepsy in adults. Options and strategies (in German). Nervenarzt 2007;78(Suppl 1):27-35
   PubMedGoogle Scholar
• Bauer J, Neumann M. Therapeutic management following diagnosis of epilepsy (in German). Fortschr Neurol Psychiat 2008;76:679-92
   PubMedGoogle Scholar
• Perucca E. Is there a role for therapeutic drug monitoring of new anticonvulsants? Clin Pharmakokin 2000;38:191-204
   Google Scholar
• Bauer J, Hermann A, Reuber M. Tolerability of high dosage carbamazepine monotherapy in treatment of epilepsy (in German). Nervenarzt 2002;73:533-7
   PubMedGoogle Scholar
• Perucca E. The new generation of antiepileptic drugs: advantages and disadvantages. Br J Clin Pharmacol 1996;42:531-43
   PubMed Web of Science ®Google Scholar
• Pack AL, Walczak TS. Bone health in women with epilepsy: clinical features and potential mechanisms. Int Rev Neurobiol 2008;83:306-28
   Google Scholar
• Helmstaedter C, Kurthen M, Lux S, et al. Chronic epilepsy and cognition: a longitudinal study in temporal lobe epilepsy. Ann Neurol 2003;54:425-32
   PubMed Web of Science ®Google Scholar
• Kwan P, Brodie MJ. Neuropsychological effects of epilepsy and antiepileptic drugs. Lancet 2001;357:216-22
   PubMed Web of Science ®Google Scholar
• Herzog AG. Disorders of reproduction and fertility. In: Engel J. Jr. and Pedley T.A., editors. Epilepsy: a comprehensive textbook. Lippincott-Raven, Philadelphia 1997;2013-26
   Google Scholar
• Bauer J, Cooper-Mahkorn D. Reproductive dysfunction in women with epilepsy: menstrual cycle abnormalities, fertility, and polycystic ovary syndrome. Int Rev Neurobiol 2008;83:136-55
   Google Scholar
• Wallace H, Shorvon S, Tallis R. Age-specific incidence and prevalence rates of treated epilepsy in an unselected population of 2,052,922 and age-specific fertility rates of women with epilepsy. Lancet 1998;352:1970-3
   PubMed Web of Science ®Google Scholar
• Meo R, Bilo L. Polycystic ovary syndrome and epilepsy. A review of the evidence. Drugs 2003;63:1185-227
   PubMedGoogle Scholar
• Knochenhauser ES, Key TJ, Kashar-Miller M, et al. Prevalence of polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. J Clin Endocrinol Metab 1998;83:3078-82
   PubMed Web of Science ®Google Scholar
• Bauer J, Isojärvi JIT, Herzog AG, et al. Reproductive dysfunction in women with epilepsy: recommendations for evaluation and management. J Neurol Neurosurg Psychiatry 2002;73:121-5
   PubMed Web of Science ®Google Scholar
• Morrell MJ. Reproductive and metabolic disorders in women with epilepsy. Epilepsia 2003;44(Suppl 4):11-20
   PubMed Web of Science ®Google Scholar
• Bauer J, Blumenthal S, Reuber M, Stoffel-Wagner B. Epilepsy syndrome, focus location, and treatment choice affect testicular function in men with epilepsy. Neurology 2004;27:243-6
   Google Scholar
• Dunn JF, Nisula BC, Rodbard D. Transport of steroid hormones: binding of 21 endogenous steroids of both testosterone-binding globulin and corticosteroid-binding globulin in human plasma. J Clin Endocrinol Metab 1981;53:58-68
   PubMed Web of Science ®Google Scholar
• Herzog AG. Reproductive endocrine considerations and hormonal therapy for men with epilepsy. Epilepsia 1991;37(Suppl 6):S34-S37
   Google Scholar
• Isojärvi JIT, TaubØll E, Herzog AG. Effect of antiepileptic drugs on reproductive endocrine function in individuals with epilepsy. CNS Drugs 2005;19:207-223
   PubMed Web of Science ®Google Scholar
• Isojärvi JIT, Pakarinen AJ, Rautio A, et al. Serum sex hormone levels after replacing carbamazepine with oxcarbazepine. Eur J Clin Pharmacol 1995;47:461-4
   PubMed Web of Science ®Google Scholar
• Patsalos PN, Zakrewska JM, Elyas AA. Dose dependent enzyme induction by oxcarbazepine. Eur J Clin Pharmacol 1990;39:187-8
   PubMed Web of Science ®Google Scholar
• Rättyä J, Pakarinen AJ, Repo M, et al. Early hormonal changes during valproate or carbamazepine treatment – a 3 months study. Neurology 2001;57:440-1
   PubMed Web of Science ®Google Scholar
• Herzog AG, Drislane FW, Schomer DL, et al. Differential effects of antiepileptic drugs on sexual function and hormones in men with epilepsy. Neurology 2005;65:1016-20
   PubMed Web of Science ®Google Scholar
• Isojärvi JIT, Löfgren E, Juntunen KST, et al. Effect of epilepsy and antiepileptic drugs on male reproductive health. Neurology 2004;62:247-53
   PubMed Web of Science ®Google Scholar
• Bauer J, Klingmüller D. Which antiepileptic drug for men with epilepsy? (in German). Nervenarzt 2008;79:1407-15
   PubMedGoogle Scholar
• Kühn KU, Quednow BB, Thiel M, et al. Antidepressive treatment in patients with temporal lobe epilepsy and major depression: a prospective study with three different antidepressants. Epilepsy Behav 2003;4:674-9
   PubMed Web of Science ®Google Scholar
• Gilliam FG, Barry JJ, Hermann BP, et al. Rapid detection of major depression in epilepsy: a multicentre study. Lancet Neurol 2006;5:399-405
   PubMed Web of Science ®Google Scholar